Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.
2.
3.

Congenital para-oesophageal hiatus hernia: an interesting family history.

Rees JE, Robertson S, McNinch AW.

Emerg Med J. 2004 Nov;21(6):749-50. No abstract available.

4.
5.
6.

Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy.

Ferdinandusse S, Denis S, Clayton PT, Graham A, Rees JE, Allen JT, McLean BN, Brown AY, Vreken P, Waterham HR, Wanders RJ.

Nat Genet. 2000 Feb;24(2):188-91.

PMID:
10655068
7.

Transverse myelitis after measles, mumps, and rubella vaccine.

Joyce KA, Rees JE.

BMJ. 1995 Aug 12;311(7002):422. No abstract available.

8.

Fluctuating dementia and rhinorrhoea.

Woollons A, Rees JE, Bradley VA.

Postgrad Med J. 1995 Apr;71(834):253. No abstract available.

9.

A prevalence survey of multiple sclerosis in Sussex.

Rice-Oxley M, Williams ES, Rees JE.

J Neurol Neurosurg Psychiatry. 1995 Jan;58(1):27-30.

10.

Impairment of memory following discrete thalamic infarction.

Parkin AJ, Rees JE, Hunkin NM, Rose PE.

Neuropsychologia. 1994 Jan;32(1):39-51.

PMID:
8818153
11.

Wernicke-Korsakoff syndrome of nonalcoholic origin.

Parkin AJ, Blunden J, Rees JE, Hunkin NM.

Brain Cogn. 1991 Jan;15(1):69-82.

PMID:
1901211
12.

The use of a biological adhesive to achieve sutureless epikeratophakia.

Brittain GP, Rostron CK, Morton DB, Rees JE.

Eye (Lond). 1989;3 ( Pt 1):56-63.

PMID:
2591599
13.

Experimental epikeratophakia with biological adhesive.

Rostron CK, Brittain GP, Morton DB, Rees JE.

Arch Ophthalmol. 1988 Aug;106(8):1103-6.

PMID:
2456752
14.

Malignant optic nerve gliomas in adults.

Rudd A, Rees JE, Kennedy P, Weller RO, Blackwood W.

J Clin Neuroophthalmol. 1985 Dec;5(4):238-43.

PMID:
3001150
15.
16.

Psychophysical assessment of a patient with Tolosa-Hunt syndrome.

Fallowfield LJ, Rees JE.

J Neurol Neurosurg Psychiatry. 1983 Jun;46(6):576-8.

17.

What the patient wants to know about Crohn's disease.

Rees JE, Mayberry JF, Calcraft B.

J Clin Gastroenterol. 1983 Jun;5(3):221-2. No abstract available.

PMID:
6863879
18.

Effect of vibration time, frequency and acceleration on drug content uniformity.

Staniforth JN, Rees JE.

J Pharm Pharmacol. 1982 Nov;34(11):700-6.

PMID:
6129298
19.

Interparticle forces in binary and ternary ordered powder mixes.

Staniforth JN, Rees JE, Lai FK, Hersey JA.

J Pharm Pharmacol. 1982 Mar;34(3):141-5.

PMID:
6121889
20.

Electrostatic charge interactions in ordered powder mixes.

Staniforth JN, Rees JE.

J Pharm Pharmacol. 1982 Feb;34(2):69-76.

PMID:
6121883
21.

Determination of interparticulate forces in ordered powder mixes.

Staniforth JN, Rees JE, Lai FK, Hersey JA.

J Pharm Pharmacol. 1981 Aug;33(8):485-90. No abstract available.

PMID:
6115921
22.

Relation between mixing time and segregation of ordered mixes.

Staniforth JN, Rees JE, Kayes JB.

J Pharm Pharmacol. 1981 Mar;33(3):175-6. No abstract available.

PMID:
6116762
23.

Visual evoked responses in pernicious anemia.

Rees JE.

Arch Neurol. 1980 Jun;37(6):397. No abstract available.

PMID:
7387479
24.

Quantifying agitation conditions in compendial dissolution tests [proceedings].

Rees JE, Yearsley TA, Kuria KA.

J Pharm Pharmacol. 1978 Dec;30 Suppl:42P. No abstract available.

PMID:
32298
25.

The effects of a dry-binder on tablet toughness [proceedings].

Rees JE, Hall SD.

J Pharm Pharmacol. 1978 Dec;30 Suppl:26P. No abstract available.

PMID:
32280
26.

Interbatch variation in compression properties of Elcema G250 [proceedings].

Rees JE, Rue PJ.

J Pharm Pharmacol. 1978 Dec;30 Suppl:25P. No abstract available.

PMID:
32279
27.

The segregation of perfect powder mixes [proceedings].

Rees JE, Staniforth JN.

J Pharm Pharmacol. 1978 Dec;30 Suppl:24P. No abstract available.

PMID:
32278
28.

Limitations of the Heckel relation for predicting powder compaction mechanisms.

Rue PJ, Rees JE.

J Pharm Pharmacol. 1978 Oct;30(10):642-3. No abstract available.

PMID:
30819
29.

Time-dependent deformation of some direct compression excipients.

Rees JE, Rue PJ.

J Pharm Pharmacol. 1978 Oct;30(10):601-7.

PMID:
30812
30.

Biopharmaceutical implications of compaction and consolidation in the design of drug dosage forms.

Rees JE.

Boll Chim Farm. 1978 Jul;117(7):375-90. No abstract available.

PMID:
743383
31.

Work-of-failure measurements on formulated tablets [proceedings].

Rees JE, Rue PJ, Richardson SC.

J Pharm Pharmacol. 1977 Dec;29 Suppl:38P. No abstract available.

PMID:
22668
32.

Elastic and visco-elastic properties of compressed tablets [proceedings].

Rees JE, Rue PJ.

J Pharm Pharmacol. 1977 Dec;29 Suppl:37P. No abstract available.

PMID:
22667
33.

"In vitro" dissolution tests for solid oral dosage forms.

Rees JE.

Boll Chim Farm. 1977 Sep;116(9):499-505. No abstract available.

PMID:
597400
34.
35.

Characterisation of pharmaceutical particulate materials.

Rees JE.

Boll Chim Farm. 1977 Mar;116(3):125-41. No abstract available.

PMID:
861084
36.

Proceedings: Evaluation of a small scale fluidized bed granulation unit.

Johnson MC, Rees JE, Sendall F.

J Pharm Pharmacol. 1975 Dec;27 Suppl?-2:80P. No abstract available.

PMID:
2758
37.

Relations between compaction data for some crystalline pharmaceutical materials.

Cole ET, Rees JE, Hersey JA.

Pharm Acta Helv. 1975;50(1-2):28-32. No abstract available.

PMID:
1114159
38.

Letter: Propranolol in Parkinson's disease.

Marsden CD, Parkes JD, Rees JE.

Lancet. 1974 Aug 17;2(7877):410. No abstract available.

PMID:
4136980
39.

Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.

Parkes JD, Baxter RC, Marsden CD, Rees JE.

J Neurol Neurosurg Psychiatry. 1974 Apr;37(4):422-6.

40.

Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Clinical features and response to levodopa.

Parkes JD, Marsden CD, Rees JE, Curzon G, Kantamaneni BD, Knill-Jones R, Akbar A, Das S, Kataria M.

Q J Med. 1974 Jan;43(169):49-61. No abstract available.

PMID:
4822972
41.
42.

Anticholinergic withdrawal and benzhexol treatment in Parkinson's disease.

Horrocks PM, Vicary DJ, Rees JE, Parkes JD, Marsden CD.

J Neurol Neurosurg Psychiatry. 1973 Dec;36(6):936-41.

43.

Density changes in lactose tablets.

Hersey JA, Rees JE, Cole ET.

J Pharm Sci. 1973 Dec;62(12):2060. No abstract available.

PMID:
4762189
44.

Physico-mechanical pre-formulation studies.

Rees JE.

Boll Chim Farm. 1973 Apr;112(4):216-25. No abstract available.

PMID:
4721645
45.

Water vapour permeability of poured and sprayed polymer films.

Pickard JF, Rees JE, Elworthy PH.

J Pharm Pharmacol. 1972 Dec;24:Suppl:139P. No abstract available.

PMID:
4144861
46.

Tableting research and technology.

Cooper J, Rees JE.

J Pharm Sci. 1972 Oct;61(10):1511-55. Review. No abstract available.

PMID:
4561201
47.

Simulation device for preliminary tablet compression studies.

Rees JE, Hersey JA, Cole ET.

J Pharm Sci. 1972 Aug;61(8):1313-5. No abstract available.

PMID:
5050385
48.

The strength of compacts containing moisture.

Rees JE, Hersey JA.

Pharm Acta Helv. 1972 Mar-Apr;47(3):235-43. No abstract available.

PMID:
5031928
49.

The use of the xenon clearance method in subarachnoid haemorrhage.

Symon L, Ackerman R, Bull JW, Du Boulay EP, Marshall J, Rees JE, Russell RW.

Eur Neurol. 1972;8(1):8-14. No abstract available.

PMID:
4559487
50.

Preliminary compaction studies using a device to simulate a rotary tabletting machine.

Cole ET, Rees JE, Hersey JA.

J Pharm Pharmacol. 1971 Dec;23:258S. No abstract available.

PMID:
4401519

Supplemental Content

Loading ...
Support Center